Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated, replacing the old Intervention / Treatment and noting Revision: v3.5.5 with Revision: v3.6.0. A recruitment status update now states No longer looking for participants, indicating the study is no longer enrolling.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision: v3.5.5 is now shown on the page, replacing Revision: v3.5.4 in the footer. This reflects a system update rather than changes to the study content.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3, indicating a software/page update rather than a change to study details.SummaryDifference0.0%

- Check61 days agoChange DetectedThe Czech location/region naming for “Olomouc Region” was updated from a different (Czech-language) form to a new display form, while keeping the same place and postal code. The page also reflects an update to the site build/revision version string.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check97 days agoChange DetectedThe site revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.